Non-invasive prenatal testing (NIPT), also known as cell-free DNA testing, is considered an important addition to the range of screening tests available for fetal chromosomal abnormalities. NIPT is considered superior to other screening tests, especially for trisomy 21 (one of the most common chromosomal abnormalities). Prenatal screening for fetal chromosomal abnormalities is done for people who want to test for fetal chromosomal abnormalities or are at high risk of fetal chromosomal abnormalities.
(Get 15% Discount on Buying this Report)
A full report of Global Non Invasive Prenatal Testing Market https://www.orionmarketreports.com/non-invasive-prenatal-testing-market/49962/
The Non Invasive Prenatal Testing key players in this market include:
- Genesis Genetics (CooperSurgical, Inc.)
- Natera, Inc.
- Centogene N.V.
- Illumina, Inc. (Verinata Health, Inc.)
- Eurofins LifeCodexx GmbH
- MedGenome Labs Ltd.
- Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
- Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
- Progenity, Inc.
- Qiagen
By Type
- Instruments
- Kits and Reagents
- Services
By Application
- Trisomy
- Microdeletions Symptoms
- Others
Scope of the Report
The research study analyses the global Non Invasive Prenatal Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Non Invasive Prenatal Testing Market Report
- What was the Non Invasive Prenatal Testing Market size in 2019 and 2021; what are the estimated growth trends and market forecast (2021-2027).
- What will be the CAGR of Non Invasive Prenatal Testing Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Non Invasive Prenatal Testing Market was the market leader in 2021?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Non Invasive Prenatal Testing market.
- The market share of the global Non Invasive Prenatal Testing market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Non Invasive Prenatal Testing market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Non Invasive Prenatal Testing market.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
